Discover

XBIT
XBiotech Inc.
2.30
2 x 1.66
2 x 2.98
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
2.34 +0.04 (1.74%)
Ytd-3.77%
1y-27.44%
2.30
day range
2.31
2.09
52 week range
3.61
Open2.31Prev Close2.30Low2.30High2.31Mkt Cap70.12M
Vol19.68KAvg Vol27.54KEPS-1.31P/EN/AForward P/E34.62
Beta1.41Short Ratio15.03Inst. Own16.19%DividendN/ADiv YieldN/A
Ex Div Date07-15Earning08-1550-d Avg2.43200-d Avg2.451yr Est13.00
Income Statement
Operating Expenses6.27M
Research and Development Expense5.21M
Selling, General and Administrative Expense1.07M
Operating Income-6.27M
Income Tax Expense49.00K
Net Income-5.50M
Net Income Common Stock-5.50M
Net Income Common Stock (USD)-5.50M
Consolidated Income-5.50M
Earnings per Basic Share-0.18
Earnings per Basic Share (USD)-0.18
Earnings per Diluted Share-0.18
Earning Before Interest & Taxes (EBIT)-5.46M
Earning Before Interest & Taxes (USD)-5.46M
Weighted Average Shares30.49M
Weighted Average Shares Diluted30.49M
Balance Sheet
Cash and Equivalents115.46M
Cash and Equivalents (USD)115.46M
Current Assets117.05M
Property, Plant & Equipment Net22.79M
Total Assets139.84M
Current Liabilities3.00M
Total Liabilities4.82M
Accumulated Retained Earnings (Deficit)-141.88M
Shareholders Equity135.02M
Shareholders Equity (USD)135.02M
Assets Non-Current22.79M
Liabilities Non-Current1.82M
Trade and Non-Trade Payables857.00K
Tax Liabilities1.93M
Cash Flow
Depreciation, Amortization & Accretion332.00K
Net Cash Flow / Change in Cash & Cash Equivalents-10.09M
Capital Expenditure9.00K
Net Cash Flow from Investing9.00K
Net Cash Flow from Operations-8.97M
Effect of Exchange Rate Changes on Cash -1.13M
Share Based Compensation172.00K